EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

TPS52 - Allergy diagnosis 11

Sunday 15 Jun, 12:45 PM - 13:45 PM Glasgow, United Kingdom
Poster Zone Thematic Poster Session
Allergy to Isobornyl Acrylate (IBOA) present in Sensors and Insulin Infusion Systems in Pediatric Population
Anaphylaxis associated with biosimilar Tocilizumab: in vitro and in vivo diagnosis
Can factors associated with relapse be predicted in patients with increased omalizumab dose intervals?
Chlorhexidine as a Hidden Everyday Allergen
Comparative Efficacy and Safety of Omalizumab Intended copy Biosimilar vs. Biologic in Chronic Spontaneous Urticaria
Descriptive and Comparative Analysis of Clinical and Endoscopic Characteristics and Treatment Response in Adult Patients with Eosinophilic Esophagitis (EoE): a preliminary experience of an Italian centre
Detailed Clinical Characterization of a Large Cohort of Chronic Spontaneous Urticaria Patients
Evaluation of allergens in Atopic Dermatitis in children between 6 months and 18years
Fixed Drug Eruption in a Patient with Vitiligo: localized patch testing as a diagnostic tool
Fixed drug eruption: exploring diagnostic considerations and triggers in a cohort study
From angioedema to Kimura disease: Diagnostic challenge
Phenotypic Clusters of Patients with Severe Chronic Spontaneous Urticaria
Searching for an Alternative Contrast Agent in a Patient Allergic to Multiple Nonionic Iodinated Contrast Media
Severe Eosinophilic Esophagitis: the Key Role of Biologics in Disease Management
Successful Management of Primary Cold Urticaria in Medical Practitioners: A Small Case Series
Systemic Histaminergic Findings in Children with Chronic Urticaria

Speakers